IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Covidien reports rise in API sales

8:57 AM MDT | April 29, 2013 | Deepti Ramesh

The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago quarter, to $127 million. Sales of APIs were considerably higher than the previous year, largely attributable to a substantial increase in sales of narcotic API products, Covidien says. During the 6-month period ended 29 March, the API business reported a 1.8% rise in sales compared with the corresponding period of the previous fiscal year, to $220...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa